Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) reports the results of the company's Eighth Annual General Meeting (AGM) held on May 21, 2008. The document details shareholder voting outcomes on various resolutions, including financial statement adoption, board elections, and corporate governance matters.
Key Financial Metrics
The filing text does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting statistics.
Material Changes Versus Prior Period
Comparative data is provided regarding shareholder participation and capital structure between the 2008 and 2007 AGMs:
- Issued Share Capital: Decreased from 5,725,158,425 shares in 2007 to 5,352,175,102 shares in 2008 (excluding Treasury Shares).
- Shareholder Population: Declined from 180,486 in 2007 to 172,581 in 2008.
- Proxy Lodgement: The percentage of shareholders lodging proxies decreased slightly from 7.95% in 2007 to 7.47% in 2008.
- Voting Participation: Total votes cast and withheld as a percentage of issued share capital remained stable, increasing marginally from 73.68% in 2007 to 73.78% in 2008.
Guidance, Outlook, and Management Commentary
The filing confirms that all 15 resolutions presented at the AGM were passed by shareholders. Notable outcomes include:
- Board Elections: Mr. Andrew Witty, Mr. Christopher Viehbacher, and Professor Sir Roy Anderson were elected, while Sir Christopher Gent, Sir Ian Prosser, and Dr. Ronaldo Schmitz were re-elected. All received over 98% of votes cast in favor.
- Remuneration Report: Approved with 85.89% of votes in favor, with 14.11% against.
- Political Expenditure: Authorization to make donations to political organizations was approved with 97.09% in favor.
- Share Buyback Authority: Authority for the company to purchase its own shares was approved with 98.23% in favor.
- Pre-emption Rights: Disapplication of pre-emption rights was approved with 98.82% in favor.
No specific forward-looking guidance, risk factors, or unusual items regarding financial operations are disclosed in this text.
Important Facts for Investor Verification
- Verify the reduction in issued share capital between 2007 and 2008 to understand the impact of share buybacks or treasury share management.
- Review the 14.11% dissent rate on the Remuneration Report, which was the highest opposition among all resolutions.
- Confirm the specific terms of the newly adopted Articles of Association and the scope of the authorized share buyback program.
- Check subsequent filings for the financial results referenced in the "Adoption of Financial Statements" resolution, as this document does not contain the financial figures themselves.